Abstract
During the past decade, there has been an enormous growth in the understanding of the fundamental abnormalities in the airways of patients with asthma. In particular, this relates to the allergen-driven inflammation within the airway wall. The safe application of fibreoptic bronchoscopy in asthma has allowed pathologists, immunologists and molecular biologists to investigate the interaction among the various resident cells and the inflammatory infiltrate in the mucosa and lamina propria [1]. At present, this approach seems to offer the best prospect for a gradual clarification of the pathogenesis of asthma. In addition, it can be envisaged that monitoring cellular presence [2], and activity [3], during therapeutic interventions will provide a rationale for the development of a more causal treatment of the disease. Hence, there is little doubt that the major improvements in future asthma therapy and prevention will be based on respiratory cell and molecular biology.

This publication has 22 references indexed in Scilit: